Medications

Most US adults with T2D meet criteria for GLP-RAs, SGLT2is

Most U.S. adults with type 2 diabetes (T2D) meet recommended criteria for use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is), but fewer than 10 percent use ...

Diabetes

Diabetes wellness visits reduce risk of amputation, study finds

Patients with diabetes who participate in a free Annual Wellness Visit covered by Medicare are 36% less likely to need an amputation, a new study from University of Virginia School of Medicine researchers and their collaborators ...

page 3 from 22